The Effect of Mastiha Oil in Metabolic Syndrome
- Conditions
- Metabolic Syndrome
- Interventions
- Dietary Supplement: Mastiha oil
- Registration Number
- NCT04785573
- Lead Sponsor
- Harokopio University
- Brief Summary
Mastiha Oil is a 100% natural product of the Mediterranean, extracted from the resin of Mastiha. Over 90 compounds have been identified in Mastiha oil, with monoterpenes exhibiting favorable effects in regulating mechanisms of oxidative stress and inflammation. The aim of this study is to determine the effect of Mastiha oil in adults with Metabolic Syndrome. 90 participants will be allocated to two groups, (45 in intervention group and 45 in control group). Mastiha oil will be provided in the form of soft gel capsules to the intervention group, whereas the control group will not consume the capsules. Both groups will receive standard nutritional counselling. The intervention will last 3 months.
The effects of the intervention will be evaluated via clinical and laboratory markers.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 94
- 30 years < Age < 75 years
- Metabolic Syndrome cardiometabolic parameters
- A stable weight for ≥ 3 months pre-intervention
- An unchanged treatment regimen for ≥ 6 months pre-intervention
- Hepatotoxic Medication
- Untreated Diabetes Mellitus
- Dysthyroidism, hypopituitarism, Cushing syndrome / disease
- Pregnancy, lactation
- Psychiatric or mental disorder
- Any use of antioxidant-phytochemical rich supplement, vitamin D supplement, anti-, pre- or pro-biotics within 3 months pre-intervention
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Intervention group Mastiha oil Participants with metabolic disorders will be subjected to nutritional counsel and the intake of 1 soft gel capsule daily for a total of 3 months.
- Primary Outcome Measures
Name Time Method Change in insulin sensitivity 3 months Levels will be evaluated pre and prost intervention in both control and intervention groups
Change in blood LDL 3 months Levels will be evaluated pre and prost intervention in both control and intervention groups
Change in blood total cholesterol 3 months Levels will be evaluated pre and prost intervention in both control and intervention groups
Change in blood triglycerides 3 months Levels will be evaluated pre and prost intervention in both control and intervention groups
- Secondary Outcome Measures
Name Time Method Change in blood CRP 3 months Levels will be evaluated pre and prost intervention in both control and intervention groups
Change in blood IL-6 3 months Levels will be evaluated pre and prost intervention in both control and intervention groups
Change in blood MPO 3 months Levels will be evaluated pre and prost intervention in both control and intervention groups
Change in blood antioxidant potential 3 months Levels will be evaluated pre and prost intervention in both control and intervention groups
Trial Locations
- Locations (2)
Harokopio University
🇬🇷Athens, Attica, Greece
Andriana Kaliora
🇬🇷Athens, Greece